Mesothelioma Trials: Antineoplaston
Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.
If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.
The Burzynski Research Institute and the National Cancer Institute are currently recruiting participants for clinical trials in order to study Antineoplaston therapy in patients with advanced mesothelioma.
The purpose of the Phase II clinical trial study is to determine the response rate and effectiveness of Antineoplaston A10 and As2-1 in mesothelioma patients.
The study is being conducted at the Burzynski Clinic in Houston, Texas. Additional information on the study can be obtained by contacting Stanislaw R. Burzynski, M.D., Ph.D.
Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.
If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.

Study of 2 drugs used to treat mesothelioma, Pemetrexed & Bevacizumab